Pfizer profit surges due to tax law 1:38pm EST - 01:00 
The drug maker behind Lipitor gained $11 billion from the new tax law, boosting its quarterly profit. As Fred Katayama reports, it said it would invest $5 billion in the U.S. over the next five years.   
The drug maker behind Lipitor gained $11 billion from the new tax law, boosting its quarterly profit. As Fred Katayama reports, it said it would invest $5 billion in the U.S. over the next five years.  //reut.rs/2DQhpYU